The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Downregulation of Angiotensin II Type 1 Receptor Gene Transcription by Nitric Oxide
Abstract
Nitric oxide (NO) plays an important role not only in the regulation of blood vessel tone, but also in the growth of vascular smooth muscle cells (VSMC). The precise mechanism involved in the inhibition of VSMC growth by NO is not known. To further explore the effect of NO on VSMC growth, we examined the effect of NO on the expression of angiotensin II type 1 receptor (AT 1-R) that is important for hypertrophy and hyperplasia of VSMC. S-nitroso acetyl DL-penicillamine (SNAP; 200μmol/L), a potent NO donor, suppressed expression level of AT 1-R mRNA by 90% and AT 1-R number by 60% after 24 hours of stimulation. The suppressive effect was dose-dependent. Actinomycin D, which is an inhibitor of gene transcription, did not affect the decrease of AT 1-R mRNA by NO. Cyclic guanosine monophosphate (cGMP) analogue, 8 bromo-cGMP, did not affect AT 1-R mRNA level. Deletion mutants of the promoter region of rat AT 1 a-R gene were fused to luciferase reporter gene and introduced to VSMC. Transfected cells were stimulated with SNAP, and luciferase activity was measured. Inhibitory effect of NO was still observed in the shortest deletion mutant that contained 61 bp upstream from transcription start site. In this DNA segment, two DNA binding protein were observed by gel mobility shift assay, and one of these binding proteins was decreased on stimulation by NO. NO downregulates AT 1-R gene expression independently of cGMP. A DNA binding protein that binds to the proximal promoter region of AT 1-R gene may be responsible for this inhibitory effect. The inhibition of AT 1-R gene expression may be implicated in the anti-atherogenic property of NO.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide synthases in mammals
Knowles, R. G., & Moncada, S. (1994) · Biochemical Journal · doi:10.1042/bj2980249 · Cited by 2,752
Cited by
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training
Fukai, T., Siegfried, M. R., Ushio-Fukai, M., Cheng, Y., Kojda, G., & Harrison, D. G. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9551 · Cited by 563
Angiotensin AT1/AT2 Receptors: Regulation, Signalling and Function
KASCHINA, E., & UNGER, T. (2003) · Blood Pressure · doi:10.1080/08037050310001057 · Cited by 458
Reporter gene technology: the future looks bright
Naylor, L. H. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00096-9 · Cited by 343
Siragy, H. M., Inagami, T., Ichiki, T., & Carey, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6506 · Cited by 328
Self-citation
Metadata
- Authors
- Ichiki, T., Usui, M., Kato, M., Funakoshi, Y., Ito, K., Egashira, K., & Takeshita, A.
- Venue
- Hypertension
- Published
- 1998-01
- Volume
- 31
- Issue
- 1
- Pages
- 342-346
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2124359761
- Cited by
- 211
- References
- 1
- FWCI
- 12.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Downregulation of Angiotensin II Type 1 Receptor Gene Transcription by Nitric Oxide. https://app.cochat.ai/papers/10.1161/01.hyp.31.1.342
- The paper
- Ichiki, T., Usui, M., Kato, M., Funakoshi, Y., Ito, K., Egashira, K., & Takeshita, A. (1998). Downregulation of Angiotensin II Type 1 Receptor Gene Transcription by Nitric Oxide. Hypertension. https://doi.org/10.1161/01.hyp.31.1.342
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.